Weifang Ruze New Material Co., Ltd.

Your Aspiration is Our Commitment

Sales & Support
Request A Quote - Email

Select Language

English
French
German
Italian
Russian
Spanish
Portuguese
Dutch
Greek
Japanese
Korean
Arabic
Hindi
Turkish
Indonesian
Vietnamese
Thai
Bengali
Persian
Polish

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote

: All Categories Halogen Free Flame Retardant Brominated Flame Retardants Weight Losing Raw Material Inorganic Bromide Cosmetic Raw Materials Antineoplastic Drugs Pharmaceutical Intermediates Plant Growth Regulators Non Small Cell Lung Cancer Medications Ovarian Cancer Medication Licorice Root Extract Pesticide Intermediates

Home Products Antineoplastic Drugs

99% Diabetes Treatment Drug Trelagliptin Succinate Cas 1029877-94-8

All Products

Halogen Free Flame Retardant (14)

Brominated Flame Retardants (6)

Weight Losing Raw Material (6)

Inorganic Bromide (6)

Cosmetic Raw Materials (19)

Antineoplastic Drugs (48)

Pharmaceutical Intermediates (147)

Plant Growth Regulators (2)

Non Small Cell Lung Cancer Medications (13)

Ovarian Cancer Medication (3)

Licorice Root Extract (14)

Pesticide Intermediates (10)

Ruze supply good service, thanks.

—— Gaurav

I'm Online Chat Now

99% Diabetes Treatment Drug Trelagliptin Succinate Cas 1029877-94-8

Large Image : 99% Diabetes Treatment Drug Trelagliptin Succinate Cas 1029877-94-8

Product Details:

Place of Origin:	Weifang,China
Brand Name:	Ruze
Certification:	COA MSDS
Model Number:	1029877-94-8

Payment & Shipping Terms:

Minimum Order Quantity:	Negotiable
Price:	Negotiable
Packaging Details:	durm
Delivery Time:	5-7 work days
Payment Terms:	L/C, T/T, Western Union, MoneyGram
Supply Ability:	1000kg/week

Contact Now

Detailed Product Description

CAS:	1029877-94-8	Color:	White Powder
Storage:	-20°C	Purity:	99%min
MF:	C22H26FN5O6	MW:	475.4701432

Advantage of our API-CAS 1029877-94-8. Trelagliptin succinate

1. High purity

2. Consistent quality for Lorlatinib

3. Competitive price

4. Fast Shipping for Lorlatinib

99% Diabetes Treatment Drug Trelagliptin Succinate Cas 1029877-94-8

Name	Trelagliptin succinate, CAS 1029877-94-8
Related APIS	Alogliptin benzoate Vildagliptin Linagliptin
Other name	1029877-94-8 Trelagliptin Succinate Trelagliptin succinat; Trelagliptin succinate Trelagliptin succinate succinate; SRY-472 SYR 111472 succinate
Key words	1029877-94-8; Antidiabetic Agents; treatment of type 2 diabetes
CAS NO.	1029877-94-8
Molecular Formula	C22H26FN5O6
Molecular Weight	475.477 g/mol

Chemical and Physical Properties
Appearance	White to off-white solid
Quality standard	Purity 99% min

Application
Drug Indication	used for the treatment of type 2 diabetes. used as an add on treatment when the first line treatment of metformin is not achieving the expected glycemic goals.
Formulations/Preparations	Tablet

Handling and storage
Safety and Hazards	The shanghai Research Institute of Chemical industry testing center identification conclusion :1 None hazard identification, 2 The substance is not subject to IATA DGR, 3 Non packing requirements.
Handling and storage	Keep container tightly closed in a dry and well-ventilated place. Light sensitive.
Sample package	Aluminium foil bag
Commercial package	Fiber drum
UN Code	Not classfied
HS Code	2934999090.00
Shipping group	Shipment at ambient temperature for no controlled and no dangerous goods
Sales restriction	NO
Origin	China

Function

SYR-472 s the world's first weekly oral DPP 4 inhibitors, used in type 2 diabetes, this product is a weekly dipeptide base peptidase IV (DPP - 4) inhibitors, through selective, sustained suppression DPP - 4, control blood sugar levels. DPP - 4 is an enzyme that can cause intestinal insulin, glucagon like peptide 1 (glp-1) promote insulin and glucose dependence polypeptide (GIP) inactivation, and these two im down insulin plays an important role in regulating blood sugar. Inhibiting dd-4 can increase blood glucose levels dependent on insulin secretion, which can control blood glucose levels.

Generally, adults take orally SYR-472 100mg once a week.

Specification

Items	Specifications	Results
Appearance	White to whitish crystal powder	Conforms
Loss on drying	NMT 0.5%	0.33%
Residue on ignition	NMT 0.1%	Conforms
Heavy metal	NMT 20ppm	Conforms
Assay (HPLC)	NLT 99.5%	99.77%
Related substances	NMT 0.5%	0.23%
Single impurity	NMT 0.1%	0.07%
Conclusion: Complies to the Enterprise standard

99% Diabetes Treatment Drug Trelagliptin Succinate Cas 1029877-94-8

We have complete experimental facilities. And advanced testing instruments ensure the stability of product quality from all aspects. We have a complete sales service system, the products are exported to countries all over the world, and have won a good international reputation with excellent quality and excellent service.Our business is based on honesty and mutual trust. Sincerely look forward to establishing long-term mutually beneficial and good cooperation with customers all over the world.

Packaging Detail	0.5kgs/Al-Bottle 1.0kgs/Al- Bottle 2.0kgs/Al- Bottle 5.0 kgs/Al-Bottle 25.0 kgs/drum or upon customers' request.
Storage	Store in a well-closed container away from moisture
Shelf Life	2 years if sealed and store away from direct sun light.
Delivery Detail	within 3 days after get the payment